Biological
AERAS-404 clinical trials
Also written AERAS-404.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 7
Aeras (7)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AERAS-404 is read from its arms, and is right about nine times in ten.
Testing it · 7
- Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy AdolescentsCompletedPhase 1AerasNCT02378207Written as H4:IC31
- Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy AdolescentsCompletedPhase 2AerasNCT02075203Written as AERAS-404
- Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed InfantsCompletedPhase 1/2AerasNCT01861730Written as AERAS-404
- A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive AdultsCompletedPhase 1AerasNCT02420444Written as AERAS-404
- A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404)CompletedPhase 1AerasNCT02109874Written as AERAS-404 (mcg H4/nmol IC31)
- A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in AdultsCompletedPhase 1AerasNCT02074956Written as AERAS-404
- A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis InfectionCompletedPhase 1AerasNCT02066428Written as AERAS-404